Characteristics and outcomes of patients with relapsed follicular lymphoma following retreatment with second-line rituximab-containing chemotherapy

Leuk Lymphoma. 2020 Oct;61(10):2492-2496. doi: 10.1080/10428194.2020.1772472. Epub 2020 Jun 10.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / therapeutic use
  • Antineoplastic Agents* / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Humans
  • Lymphoma, Follicular* / drug therapy
  • Retreatment
  • Rituximab / therapeutic use

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab